|
|
|
Insider
Information: |
Brockstedt Dirk G. |
Relationship: |
|
City: |
Berkeley |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
152,423 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,144,830 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
152,423 |
|
|
Total
Value |
$5,144,830 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-107.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Chinook Therapeutics Inc |
KDNY |
EVP of Research and Dev. |
2017-12-29 |
124,603 |
2015-11-16 |
0 |
Premium* |
|
Rapt Therapeutics, Inc. |
RAPT |
|
2024-01-05 |
27,820 |
2020-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
|
2017-10-02 |
4 |
AS |
$10.59 |
$105,870 |
D/D |
(10,000) |
73,718 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
|
2017-04-03 |
4 |
AS |
$10.71 |
$85,645 |
D/D |
(8,000) |
49,300 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
|
2017-09-13 |
4 |
S |
$10.99 |
$39,076 |
D/D |
(3,557) |
73,718 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
|
2017-03-09 |
4 |
AS |
$11.00 |
$88,001 |
D/D |
(8,000) |
49,300 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
|
2017-07-03 |
4 |
AS |
$11.02 |
$110,167 |
D/D |
(10,000) |
49,300 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
|
2017-09-01 |
4 |
AS |
$11.69 |
$116,948 |
D/D |
(10,000) |
49,300 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
|
2017-01-17 |
4 |
AS |
$11.86 |
$94,858 |
D/D |
(8,000) |
49,300 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
|
2017-08-07 |
4 |
AS |
$12.18 |
$121,795 |
D/D |
(10,000) |
49,300 |
0 |
- |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2020-05-15 |
4 |
AS |
$15.00 |
$148,155 |
D/D |
(9,877) |
10,256 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2022-05-04 |
4 |
AS |
$15.05 |
$10,836 |
D/D |
(720) |
19,812 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2020-11-16 |
4 |
AS |
$17.01 |
$168,008 |
D/D |
(9,877) |
10,256 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2021-05-11 |
4 |
AS |
$18.19 |
$48,167 |
D/D |
(2,648) |
19,812 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2021-06-11 |
4 |
AS |
$18.55 |
$49,102 |
D/D |
(2,647) |
19,812 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2021-01-06 |
4 |
AS |
$19.68 |
$23,203 |
D/D |
(1,179) |
17,556 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2021-01-05 |
4 |
AS |
$19.76 |
$16,225 |
D/D |
(821) |
18,735 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2021-02-16 |
4 |
AS |
$21.22 |
$209,590 |
D/D |
(9,877) |
19,812 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2021-05-05 |
4 |
AS |
$21.56 |
$44,931 |
D/D |
(2,084) |
19,812 |
0 |
% |
|
KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
|
2016-01-11 |
4 |
AS |
$21.57 |
$479,015 |
D/D |
(22,000) |
12,000 |
0 |
- |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2023-01-05 |
4 |
S |
$21.97 |
$16,299 |
D/D |
(742) |
19,070 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2022-02-11 |
4 |
AS |
$22.47 |
$59,478 |
D/D |
(2,647) |
19,812 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
CHIEF SCIENTIFIC OFFICER |
|
2024-01-05 |
4 |
S |
$22.78 |
$20,456 |
D/D |
(898) |
27,820 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2022-04-11 |
4 |
AS |
$23.05 |
$61,013 |
D/D |
(2,647) |
19,812 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2020-08-17 |
4 |
AS |
$23.13 |
$236,328 |
D/D |
(9,877) |
10,256 |
0 |
% |
|
RAPT |
Rapt Therapeutics, Inc. |
Chief Scientific Officer |
|
2022-03-11 |
4 |
AS |
$23.91 |
$63,314 |
D/D |
(2,648) |
19,812 |
0 |
% |
|
KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
|
2015-11-16 |
4 |
AS |
$27.50 |
$204,294 |
D/D |
(7,423) |
0 |
0 |
- |
|
86 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|